BioSpace News Archive

Microplate readers (MR) are laboratory instruments used for the measurement of analytes and monitoring the progression of biochemical reactions carried out in microplates.

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, today reported its financial results for the second quarter ended June 30, 2022 and highlighted recent corporate progress.

Acer Therapeutics Inc. (Nasdaq: ACER), today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

Athira Pharma, Inc. (NASDAQ: ATHA), today announced the company’s financial results for the second quarter ended June 30, 2022 and reviewed recent clinical and corporate updates.

Icosavax, Inc. (Nasdaq: ICVX), today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine.

Blue Water Vaccines Inc. announced its financial results for the second quarter ended June 30, 2022 and provided an update on recent business developments and progress.

Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today provided a corporate update and reported its financial results for the quarter ended June 30, 2022.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), today announced financial results for the second quarter ended June 30, 2022 and highlighted recent pipeline and business progress.

SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended June 30, 2022.